Globant S.A [GLOB] vs Genpact [G] Detailed Stock Comparison
Globant S.A
NYSE
Loading...
Genpact
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Globant S.A wins in 7 metrics, Genpact wins in 12 metrics, with 0 ties. Genpact appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Globant S.A | Genpact | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.70 | 14.51 | Genpact |
| Price-to-Book Ratio | 1.42 | 2.94 | Globant S.A |
| Debt-to-Equity Ratio | 24.51 | 59.21 | Globant S.A |
| PEG Ratio | -0.83 | 1.23 | Globant S.A |
| EV/EBITDA | 9.71 | 10.34 | Globant S.A |
| Profit Margin (TTM) | 4.44% | 10.92% | Genpact |
| Operating Margin (TTM) | 4.03% | 14.75% | Genpact |
| EBITDA Margin (TTM) | 4.03% | 14.75% | Genpact |
| Return on Equity | 5.55% | 21.86% | Genpact |
| Return on Assets (TTM) | 4.44% | 8.71% | Genpact |
| Free Cash Flow (TTM) | $135.11M | $530.19M | Genpact |
| Dividend Yield | N/A | 1.12% | N/A |
| 1-Year Return | -66.79% | 13.83% | Genpact |
| Price-to-Sales Ratio (TTM) | 1.20 | 1.54 | Globant S.A |
| Enterprise Value | $3.38B | $8.47B | Genpact |
| EV/Revenue Ratio | 1.36 | 1.72 | Globant S.A |
| Gross Profit Margin (TTM) | 34.89% | 35.88% | Genpact |
| Revenue per Share (TTM) | $57 | $28 | Globant S.A |
| Earnings per Share (Diluted) | $2.45 | $3.01 | Genpact |
| Beta (Stock Volatility) | 1.16 | 0.93 | Genpact |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Globant S.A vs Genpact Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Globant S.A | 3.63% | -13.62% | -21.29% | -34.33% | -55.52% | -68.33% |
| Genpact | 1.80% | 1.88% | -0.85% | 1.95% | -16.39% | 3.56% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Globant S.A | -66.79% | -68.44% | -61.71% | 144.85% | 499.82% | 499.82% |
| Genpact | 13.83% | -4.50% | 4.24% | 90.01% | 214.85% | 182.67% |
Performance & Financial Health Analysis: Globant S.A vs Genpact
| Metric | GLOB | G |
|---|---|---|
| Market Information | ||
| Market Cap | $2.99B | $7.61B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,338,130 | 2,005,413 |
| 90 Day Avg. Volume | 1,637,780 | 1,557,408 |
| Last Close | $69.93 | $45.32 |
| 52 Week Range | $64.51 - $238.32 | $37.82 - $56.76 |
| % from 52W High | -70.66% | -20.16% |
| All-Time High | $354.62 (Nov 08, 2021) | $56.76 (Feb 03, 2025) |
| % from All-Time High | -80.28% | -20.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.07% |
| Quarterly Earnings Growth | 0.07% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | 0.11% |
| Operating Margin (TTM) | 0.04% | 0.15% |
| Return on Equity (TTM) | 0.06% | 0.22% |
| Debt to Equity (MRQ) | 24.51 | 59.21 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $47.86 | $14.84 |
| Cash per Share (MRQ) | $3.93 | $3.83 |
| Operating Cash Flow (TTM) | $315.46M | $649.51M |
| Levered Free Cash Flow (TTM) | $165.73M | $528.06M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.12% |
| Last 12-Month Dividend | N/A | $0.47 |
Valuation & Enterprise Metrics Analysis: Globant S.A vs Genpact
| Metric | GLOB | G |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.70 | 14.51 |
| Forward P/E | 9.16 | 12.66 |
| PEG Ratio | -0.83 | 1.23 |
| Price to Sales (TTM) | 1.20 | 1.54 |
| Price to Book (MRQ) | 1.42 | 2.94 |
| Market Capitalization | ||
| Market Capitalization | $2.99B | $7.61B |
| Enterprise Value | $3.38B | $8.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.36 | 1.72 |
| Enterprise to EBITDA | 9.71 | 10.34 |
| Risk & Other Metrics | ||
| Beta | 1.16 | 0.93 |
| Book Value per Share (MRQ) | $47.86 | $14.84 |
Financial Statements Comparison: Globant S.A vs Genpact
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GLOB | G |
|---|---|---|
| Revenue/Sales | $611.09M | $1.25B |
| Cost of Goods Sold | $397.86M | $804.35M |
| Gross Profit | $213.23M | $450.07M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $51.54M | $179.40M |
| EBITDA | $50.29M | $215.90M |
| Pre-Tax Income | $38.99M | $176.74M |
| Income Tax | $8.49M | $44.02M |
| Net Income (Profit) | $30.50M | $132.72M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GLOB | G |
|---|---|---|
| Cash & Equivalents | $114.00M | $561.62M |
| Total Current Assets | $875.55M | $1.94B |
| Total Current Liabilities | $559.80M | $791.74M |
| Long-Term Debt | $373.24M | $1.36B |
| Total Shareholders Equity | $2.12B | $2.45B |
| Retained Earnings | $893.46M | $1.27B |
| Property, Plant & Equipment | $268.34M | $984.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GLOB | G |
|---|---|---|
| Operating Cash Flow | $104.12M | $189.46M |
| Capital Expenditures | N/A | $-21.98M |
| Free Cash Flow | $-5.71M | $17.86M |
| Debt Repayment | N/A | $-8.97M |
| Common Stock Repurchase | N/A | $-62.99M |
Short Interest & Institutional Ownership Analysis
| Metric | GLOB | G |
|---|---|---|
| Shares Short | 3.78M | 6.93M |
| Short Ratio | 3.33 | 5.37 |
| Short % of Float | 0.10% | 0.05% |
| Average Daily Volume (10 Day) | 2,338,130 | 2,005,413 |
| Average Daily Volume (90 Day) | 1,637,780 | 1,557,408 |
| Shares Outstanding | 44.03M | 174.66M |
| Float Shares | 40.01M | 159.76M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.04% | 1.05% |
Dividend Analysis & Yield Comparison: Globant S.A vs Genpact
| Metric | GLOB | G |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.47 |
| Last 12-Month Dividend Yield | N/A | 1.12% |
| 3-Year Avg Annual Dividend | N/A | $0.48 |
| 3-Year Avg Dividend Yield | N/A | 0.37% |
| 3-Year Total Dividends | N/A | $1.43 |
| Ex-Dividend Date | N/A | Mar 11, 2025 |